Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
828.1 USD | +16.88% |
|
-.--% | +6.17% |
06-25 | Mirabaud Securities Lifts Price Target on EMS-Chemie Holding AG, Maintains Hold Recommendation | MT |
05-09 | Berenberg Lifts Price Target on EMS-Chemie, Maintains Hold Recommendation | MT |
Summary
- The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
Strengths
- The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.
- The group's activity appears highly profitable thanks to its outperforming net margins.
- Thanks to a sound financial situation, the firm has significant leeway for investment.
- There is high visibility into the group's activities for the coming years. Outlooks on future revenues from analysts covering the equity remain similar. Such hardly dispersed estimates support highly predictable sales for the current and upcoming fiscal years.
- The group usually releases upbeat results with huge surprise rates.
Weaknesses
- The potential for earnings per share (EPS) growth in the coming years appears limited according to current analyst estimates.
- The company's valuation in terms of earnings multiples is rather high. Indeed, the firm is getting paid 38.61 times its estimated earnings per share for the ongoing year.
- Based on current prices, the company has particularly high valuation levels.
- In relation to the value of its tangible assets, the company's valuation appears relatively high.
- The valuation of the company is particularly high given the cash flows generated by its activity.
- For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
- The three month average target prices set by analysts do not offer high potential in comparison with the current prices.
- The overall consensus opinion of analysts has deteriorated sharply over the past four months.
- Over the past twelve months, analysts' consensus has been significantly revised downwards.
Ratings chart - Surperformance
Sector: Specialty Chemicals
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+6.17% | 19.17B | - | ||
+19.99% | 67.97B | A- | ||
-6.03% | 45.92B | A- | ||
+22.27% | 43.74B | B+ | ||
+33.20% | 28.16B | A- | ||
+14.71% | 17.12B | B+ | ||
-13.18% | 14.73B | B+ | ||
-27.99% | 14.52B | A- | ||
-32.33% | 11.64B | A- | ||
-33.89% | 11.23B | C+ |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- EMSN Stock
- EMSHF Stock
- Ratings EMS-CHEMIE HOLDING AG